OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Key molecular scaffolds in the development of clinically viable α-amylase inhibitors
Rahul Pratap Singh, Jayant Sindhu, Devender Singh, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 347-362
Closed Access

Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress
Manan Kothari, K. K. Kannan, Revathy Sahadevan, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130175-130175
Closed Access | Times Cited: 4

Quercetin analogs as α-glucosidase inhibitors with antidiabetic activity
Honghui Liu, Yan Wang, Jing Tong, et al.
Food Bioscience (2024) Vol. 58, pp. 103713-103713
Closed Access | Times Cited: 3

Integrating Pharmacological and Computational Approaches for the Phytochemical Analysis of Syzygium cumini and Its Anti-Diabetic Potential
Fatima Rashid, Anam Javaid, Mahmood Ur Rahman, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5734-5734
Open Access | Times Cited: 12

Design of highly active substrates using molecular docking for microbial transglutaminase detection
Longhao Zou, Xu Geng, Zhengqiang Li, et al.
RSC Advances (2023) Vol. 13, Iss. 8, pp. 5259-5265
Open Access | Times Cited: 5

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity
Honghui Liu, Puxin Huang, Xingchen Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107059-107059
Closed Access | Times Cited: 5

N -Arylacetamide derivatives of methyl 1,2-benzothiazine-3-carboxylate as potential drug candidates for urease inhibition
Sajila Hina, Sumera Zaib, Maliha Uroos, et al.
Royal Society Open Science (2023) Vol. 10, Iss. 4
Open Access | Times Cited: 3

Step‐Economical Mechanosynthesis of Hybrid Azoles: Deciphering Their π‐Orbital and Pharmacological Characteristics
Ramachandran Sundaramoorthy, Murugan Vadivelu, Thirumoorthy Kulandaivel, et al.
ChemMedChem (2023) Vol. 18, Iss. 13
Closed Access | Times Cited: 3

Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent
Fatima Rashid, Matloob Ahmad, Usman Ali Ashfaq, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 4043-4060
Open Access | Times Cited: 5

Carbohydrazide-Based schiff bases for selective Hg (II) ion sensing and computational analysis of cholesterol lowering activity
Gurjaspreet Singh, Sudha Malik, Anita Devi, et al.
Inorganic Chemistry Communications (2024) Vol. 163, pp. 112297-112297
Closed Access

In vivo anti-diabetic and anti-lipidemic evaluations of an excellent synthetic α-glucosidase inhibitor with dihydropyrano[3,2-c]quinoline skeleton
Maryam Mohammadi‐Khanaposhtani, Navid Bakhtiari, Fatemeh Bandarian, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 2375-2384
Closed Access

Apigenin analogs as α-glucosidase inhibitors: Molecular docking, biochemical, enzyme kinetic, and an in vivo mouse model study
Honghui Liu, Yau‐Huei Wei, Yan Wang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107956-107956
Closed Access

Lipophilic derivatives of EGCG as potent α-amylase and α-glucosidase inhibitors ameliorating oxidative stress and inflammation
Manan Kothari, K. K. Kannan, Revathy Sahadevan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107786-107786
Closed Access

In vivo and in silico evaluations of a synthetic pyrano[3,2-c]quinoline derivative as a potent anti-diabetic agent
Nafiseh Zare, Fatemeh Bandarian, Ensieh Nasli‐Esfahani, et al.
Journal of Diabetes & Metabolic Disorders (2023) Vol. 23, Iss. 1, pp. 809-815
Closed Access | Times Cited: 1

Page 1

Scroll to top